|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/28 | (2013.01) |
| A61K 45/06 | (2006.01) | ||
| A61K 31/5578 | (2006.01) | ||
| A61K 31/137 | (2013.01) | ||
| A61K 31/472 | (2013.01) | ||
| A61K 31/137 | (2006.01) | ||
| A61K 31/472 | (2006.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61K 31/519 | (2006.01) | ||
| C07K 14/62 | (2013.01) | ||
| A61K 31/557 | (2006.01) | ||
| C07D 487/04 | (2013.01) | ||
| A61K 31/5585 | (2006.01) | ||
| A61K 9/0019 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 31/557 | (2013.01) | ||
| A61K 38/28 | (2006.01) | ||
| A61K 31/5585 | (2013.01) | ||
| A61P 3/10 | (2006.01) | ||
| C07D 217/20 | (2013.01) | ||
| C07C 215/60 | (2006.01) | ||
| A61K 31/5578 | (2013.01) | ||
| C07C 59/46 | (2006.01) | ||
| A61P 3/10 | (2018.01) | ||
| C07D 215/20 | (2006.01) | ||
| C07D 217/20 | (2006.01) | ||
| C07D 487/04 | (2006.01) | ||
| C07K 14/62 | (2006.01) |
| (11) | Number of the document | 3328388 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16829537.6 |
| Date of filing the European patent application | 2016-07-28 | |
| (97) | Date of publication of the European application | 2018-06-06 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CA2016/050886 |
| Date | 2016-07-28 |
| (87) | Number | WO 2017/015760 |
| Date | 2017-02-02 |
| (30) | Number | Date | Country code |
| 201562197833 P | 2015-07-28 | US |
| (72) |
ARDILOUZE, Jean-luc , CA
GAGNON-AUGER, Maude , CA
GOBEIL, Fernand , CA
MENARD, Julie , CA
BAILLARGEON, Jean-Patrice , CA
BRASSARD, Pascal , CA
|
| (73) |
Eli Lilly and Company ,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | A PHARMACEUTICAL PREPARATION FOR IMPROVING ABSORPTION AND POSTPRANDIAL HYPOGLYCEMIC ACTION OF INSULIN |
| A PHARMACEUTICAL PREPARATION FOR IMPROVING ABSORPTION AND POSTPRANDIAL HYPOGLYCEMIC ACTION OF INSULIN |